Table 4.
Number of false-positives*
| Females | Males | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Up-to-date with colorectal cancer screening |
Up-to-date with breast cancer screening |
Up-to-date with colorectal cancer screening |
||||
|
|
||||||
| Column | (1) | (2) | (3) | |||
|
|
||||||
| AOR (95% CI) |
P for trend |
AOR (95% CI) |
P for trend |
AOR (95% CI) |
P for trend |
|
| Number of false-positive breast cancer screenings | ||||||
| 0 | Ref. | Ref. | ||||
| 1 | 1.16 (1.10–1.23) | <0.001 | 1.34 (1.26–1.43) | <0.001 | ||
| ≥2 | 1.50 (1.35–1.67) | 2.63 (2.23–3.10) | ||||
| Number of false-positive prostate cancer screenings | ||||||
| 0 | Ref. | |||||
| 1 | 1.18 (1.05–1.32) | 0.005 | ||||
| ≥2 | 1.40 (1.11–1.71) | |||||
| Psuedo-R2 | 0.52 | 0.40 | 0.59 | |||
| Number of person-years | 262,242 | 262,242 | 188,242 | |||
| Number of individuals | 52,871 | 52,871 | 39,534 | |||
*
Nnumber of false-positive FOBTs was not assessed, because average risk patients with 1 false-positive and a negative follow-up colonoscopy would not be expected to re-screen during the sample period. Adjusted for covariates as described in manuscript.